Anakinra, a drug used in some autoinflammatory diseases and familial Mediterranean fever (FMF), blocks IL-1 alpha and beta at the IL-1 receptor, thus inhibiting IL-1 pro-inflammatory effects [60]. The gene discussed is IL1B; the disease is familial Mediterranean fever.